Kaempferol has been shown to protect against chemotherapeutic drug-induced cardiotoxicity and improve advanced tumor cardiac cachexia by inhibiting p53-mediated mitochondria-dependent apoptotic signaling and regulating in ERK-dependent mitogen-activated protein kinase pathway in in vitro and in vivo assays (37). This evidence concerns the gene TP53 and neoplasm.